Unimpressed with the environmental assessment the Food and Drug Association used to approve a new breed of genetically modified salmon destined for the American dinner table, a federal judge looked poised Tuesday to rule in favor of environmental groups afraid of its potential to blunt wild salmon populations.
At a hearing Tuesday, U.S. District Judge Vincent Chhabria said he’s concerned that AquaBounty, the biotech company behind the GMO salmon, might use the FDA’s finding of “no significant impact” to expand the program without realizing its full impact on local ecology.
AquaBounty plans to breed its “AquAdvantage” salmon — a genetic mix of ocean pout and Pacific Chinook — at its hatchery in Rollo Bay on Prince Edward Island, then transport the eggs for growth at its Indiana farm site. That is, if litigation doesn’t stand in the way.
To read the rest of the story, please go to: Courthouse News Service
